Global Pharmaceutical Grade Sodium Chloride Market is Segmented By Type (API-NaCl, HD-NaCl), By Application (Haemodialysis, Injections, Oral Rehydration Salt (ORS), Peritoneal Dialysis, Hemofiltration Solutions, Channeling agents/ osmotic agent, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Pharmaceutical Grade Sodium Chloride Market Overview
The global pharmaceutical grade sodium chloride market is estimated to at a high CAGR during the forecast period (2023-2030).
Sodium chloride (Pharma Grade), common salt, table salt, or halite, is a white crystalline solid with NaCl, representing a 1:1 sodium and chloride ions ratio.
Sodium chloride is one of the most plentiful minerals on the planet and a necessary nutrient for various animals and plants. Pharmaceutical grade sodium chloride, often known as pharmaceutical salt, is a screened, granular, white crystalline sodium chloride produced under strict process control techniques under GMP guidelines for pharmaceutical production.
Pharmaceutical-grade sodium chloride is predicted to have the largest market in North America. On the other hand, Asia-Pacific would emerge as the largest market due to its growing spending capacity. Injections, hemodialysis, peritoneal dialysis, hemofiltration solutions, oral rehydration salts (ORS), channeling agents/osmotic agents, mechanical cleansing solutions, and others are among the applications for pharmaceutical grade sodium chloride (dietary formulations and infant formulations).
The major end-use industry that drives the market is the pharmaceutical sector, which produces products used in applications such as injections, hemodialysis, oral rehydration salts, and others. All industries have been negatively affected by Covid-19. Still, the market is predicted to develop significantly over the projected period because of increased demand from end-use industries, likely increasing the need for sodium chloride of the pharmaceutical grade.
Pharmaceutical Grade Sodium Chloride Market Scope
|
Metrics |
Details |
|
Market CAGR |
High |
|
Segments Covered |
By Type, By Application, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other vital insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To Get a Free Sample Click here
Pharmaceutical Grade Sodium Chloride Market Dynamics
The rising prevalence of chronic and kidney diseases globally is one of the major factors improving the growth of the pharmaceutical-grade sodium chloride market.
The rising prevalence of chronic and kidney diseases globally acts as one of the major factors improving the growth of the pharmaceutical-grade sodium chloride market
Changing lifestyles and eating patterns in emerging and developed countries have resulted in many lifestyle diseases, including cardiovascular disease, chronic or late-stage renal disease, and diarrhea. Exposure to these diseases is significant in industrialized countries like the U.S. and the EU-5, resulting in higher healthcare costs.
Pharmaceutical-grade sodium chloride is required for various applications such as dialysis solutions (hemodialysis, peritoneal dialysis, extraction of biological heparin, hemofiltrationoral rehydration salts, channeling agents, osmotic agents, cleansing solutions), intravenous (IV) injections, pharmaceutical formulations, nutrition (enteral, parenteral) and non-medical applications (corrosion testing, cosmetics, etc.).
Dialysis dominates the global market with a 50% share due to the growing incidence of renal failure worldwide. As spending in the healthcare sector rises, the pharmaceutical-grade sodium chloride market is similarly driven by rising global wealth. Dialysis is an artificial cleaning method for the blood of waste products to replace lost kidney functions.
Renal dialysis is a lifeline for an increasing number of patients worldwide. It is the only option for many because kidney transplantation is not an option due to a scarcity of donor organs. The main component of dry and liquid hemodialysis concentrates and peritoneal dialysis solutions is sodium chloride.
End-stage renal disease (ESRD) patients are treated with a kidney transplant or dialysis. However, compared to the commonly used dialysis procedure, the rate of kidney transplants is fairly low due to less availability of kidney donors and various other medical issues. As a result, dialysis is majorly used to treat most ESRD patients.
Among dialysis types, around 90% of the patients preferred hemodialysis, while the rest preferred peritoneal dialysis. As per the National Kidney Foundation, in 2018, 785,883 Americans were diagnosed with kidney failure and required dialysis or liver transplant (2 in every 1,000 people). In 2018, dialysis was used for kidney function replacement in 554,038 patients and 229,887 had a kidney transplant.
Furthermore, In 2018, around 130,000 patients began KFRT treatment, with roughly 128,000 beginning dialysis as their first treatment modality. A kidney transplant was performed on 22,393 patients in 2018. 229,887 Americans received a kidney transplant at the end of 2018.
Stringent government regulations for pharmaceutical-grade sodium chloride have hampered the growth of the market
The demand for pharmaceutical-grade sodium chloride has increased significantly in recent years. However, rising demand for the product has built more regulatory bodies, hampering the growth of pharmaceutical-grade sodium chloride.
The key players are forced to satisfy the extremely strict requirements in pharmaceutical manufacturing processes, particularly pure pharmaceutical-grade salt exceeding the purity requirements stipulated in various pharmacopeias.
COVID-19 Impact on Pharmaceutical-Grade Sodium Chloride Market Growth
The sudden emergence of the COVID-19 pandemic prompted strict lockdown measures in some countries, causing delays in importing and exporting pharmaceutical-grade sodium chloride.
Due to a low worker force, industrial facility closures, and supply chain disruptions worldwide, the recent COVID-19 pandemic has negatively influenced the global pharmaceutical-grade sodium chloride market size. However, the addition of high-purity sodium chloride solution for coronavirus vaccines has increased the demand for the product tremendously, leading to improved demand during the pandemic phase.
Every hospital's well-known 0.9% infusion solution is an important standard pharmaceutical product. The basic ingredient contained is high-purity sodium chloride (NaCl). The product presently plays a significant part in the worldwide administration of the Biotech/Pfizer vaccine, which is currently underway: The vaccine must first be diluted with 1.8 mL NaCl per dosage before being injected.
Thus rising vaccination drive across the globe has enormous huge opportunities for pharmaceutical-grade sodium chloride leading to improve market opportunities for the product in the forecast period.
Pharmaceutical Grade Sodium Chloride Market Segment Analysis
The global pharmaceutical-grade sodium chloride market can be segmented by type, application, and region.
API-NaCl has shown rising growth in the global pharmaceutical-grade sodium chloride market due to the increasing demand for the product in various pharmaceutical applications
The global pharmaceutical grade sodium chloride market is segmented on type into API-NaCl and HD-NaCl. Out of the mentioned type, API-NaCl holds a significant market share in the global pharmaceutical-grade sodium chloride market. API-NaCl is an active pharmaceutical ingredient. The ingredient is ideal for manufacturing parenteral and enteral infusion solutions and further pharmaceutical applications.
API-NaCl is s used in ophthalmic, dialysis, clinical nutrition, and infusion solutions, and the increasing prevalence of kidney disorders has recently accelerated the demand for the segment.
Pharmaceutical Grade Sodium Chloride Market Geographical Share
Asia-Pacific has shown unprecedented market growth in the pharmaceutical-grade sodium chloride market due to the rising dialysis patient population and stringent government policies
The global consumption of pharmaceutical-grade sodium chloride is expected to grow significantly in the forecast period. The market is constantly expanding, with North America leading the way, Asia-Pacific, and Europe. U.S., Germany, and Japan are among the world's top consumers. Asia-Pacific area, which includes China, India, Indonesia, Vietnam, and other countries, is the fastest expanding market, followed by North America and Europe.
Furthermore, government-imposed strict laws or regulations have impeded the market's expansion in the region. Similarly, the market's growth has been hampered by low profitability. On the other hand, pure and certified salt and expanding spending capacity in emerging countries are projected to create more prospects.
Furthermore, due to the enormous growth of the pharmaceutical business in North America, signifchangegrowth is anticipated in the forecast peA rise in demand from the local healthcare sector in the region drives the market for pharmaceutical-grade sodium chlorideregion.
The U.S. dominates the healthcare industry in North America because of its superior healthcare infrastructure and substantial investments in pharmaceutical and healthcare research and development. Despite extensive testing and more sophisticated medicines, the World Health Organization reported higher rates of medical treatment for resistant patients than those with non-resistible illnesses.
Pharmaceutical Grade Sodium Chloride Companies and Competitive Landscape
The global pharmaceutical-grade sodium chloride market is highly competitive with local and global companies. Some prime companies contributing to the market's growth are Sudsalz, Cheetham Salt, AkzoNobel [Sanal Pharma], K+S AG, Dominion Salt, Cargill Incorporated, Salinan Austria AG, Hub Salt, and others.
K+S AG
Overview: K+S AG is a chemical firm based in Kassel, Germany. After acquiring Morton Salt, the company became Europe's growing supplier of potash for fertilizer and the world's growing salt producer. Other mineral fertilizers, such as magnesium and sulfur, are also produced and distributed. With about 14,000 people worldwide, K+S is primarily active in Europe and North and South America. The company holds various subsidiaries such as K+S Potash Canada GP, based in Saskatoon, Canada, K+S KALI GmbH, based in Kassel, Germany, Esco-European salt company GmbH & Co.KG, based in Hannover, Germany, Chemische Fabrik Kalk, based in Cologne, Germany, K+S Transport GmbH, based in Hamburg, Germany.
Product Portfolio: The company has a product portfolio of pharmaceutical-grade sodium chloride that includes:
- APISAL: APISAL is a pharmaceutically active ingredient used in dialysis, enteral and parenteral solutions, and other pharmaceutical applications. K+S creates a highly pure pharmaceutical-grade salt that exceeds the purity requirements in several pharmacopeias to meet the extremely stringent requirements in pharmaceutical production processes. The product includes properties such as Low content of minerals, Highest purity, Good Manufacturing Practice (GMP)—ICH Q7 and Complies with the requirements of the following pharmacopeias: Ph. Eur., USP, BP, JP, CEP certificate, FDA registration, US Drug Master File (DMF), Kosher and HALAL certification
- Under GMP/GDP guidelines, APISAL sodium chloride is packaged and kept apart from all other production facilities. It is created in discrete batches and then examined. With each delivery, a unique certificate of analysis is sent.
